Effective immediately: French purchasing group Francap starts pooling procurement of their strong private label brands under the international umbrella of the EMD Alliance
17.1.2025 12:00:00 CET | news aktuell GmbH | Press release
Right at the start of 2025, the European Marketing Distribution (EMD) network is once again demonstrating the additional benefits that cooperation between renowned distributors can generate for customers in the retail sector: The latest example is a new cooperation on the joint procurement of private labels in France with the renowned buying group Francap, who serves 10 local retailers, representing over 2,200 points of sale, including the French operations of EMD's Belgian partner Colruyt.
As a result, French consumers can now enjoy even more attractive private label product ranges in the affiliated Francap shops - and suppliers in France gain new and valuable access to the global sales markets of the EMD retail alliance.

Pfäffikon/Switzerland, 17/01/2025:
In order to clarify the dynamics for all the stakeholders involved, it is worth taking a closer look at the networked structures. Francap, which has been operating successfully in France for over 60 years, has 10 members-retailers that currently represent 2,215 outlets in France and are particularly successful with customers when it comes to local shopping, offering a full range of products.
Francap is recognised in France as a reliable purchasing organisation for supermarket chains such as Coccinelle Supermarché, Diagonal, G20 and Colruyt. Colruyt France, one of the major Francap members, is already operating 102 supermarkets in France.
Francap also supplies well-established local supply specialists such as Rapid’ Market, Sitis, Epi Service, Votre marché, Panier Sympa, Viveco and Marché Minut’.
Including the revenues of Colruyt France, the Francap Group represents a cumulated consumer turnover of 3.5 billion euros.
High-performance own brands form the focus of the collaboration
The primary objective of the collaboration recently initiated by Francap under the aegis of the EMD alliance is the joint procurement and marketing of high-performance private labels. These products are experiencing increased popularity in the discerning French food market. The Francap Group already has a range of well-established own brands (such as Belle France, Les Délices de Belle France and Ecoprix), while EMD can enrich the product range of its new purchasing partner Francap with its large portfolio of highly sought-after private labels under the EMD Eurolabel.
The cooperation between Francap and EMD concerns only private label products: no collaboration on the international marketing nor procurement of A-brand products is in the scope of the collaboration.
Numerous new initiatives have emerged in the goods sector, offering mutual benefits.
The networking of all the aforementioned partners has triggered a number of significant developments, particularly for French retail customers, who now have an even more appealing selection of very good and always affordable private labels at their disposal. The combined professional expertise of Francap is incorporated into EMD's international product group tenders by the joint purchasing teams. EMD itself is opening up a new route into the French food market for international own-brand manufacturers, while French manufacturers can look forward to new opportunities in EMD's intercontinental distribution area.
EMD, which celebrated its 35th anniversary in the past 2024 together with all its members and partners from industry and trade, will remain a particularly reliable and cooperative partner in the international procurement and marketing market also in the new year 2025.
About EMD:
European Marketing Distribution AG, headquartered in Pfäffikon, Switzerland, has been recognised in the consumer goods industry as an efficient and powerful partner for fast-moving consumer goods (FMCG) since 1989. In particular, it develops and procures highly efficient and sustainably produced private label concepts for the benefit of consumers. The EMD head office also supports and realises global partnerships in the area of on-top agreements with the largest brand manufacturers.
In 2024, EMD announced new memberships in Germany (RTG International) and in South Korea (Lotte). Woolworths Australia left the cooperation end 2024.
Including the associate member Lotte from South Korea, the EMD member companies in Europe and Asia currently represent an external retail consumer turnover of approx. 200 billion euros in 16 countries.
The member companies of European Marketing Distribution (EMD) are active in the following markets:
Austria: MARKANT Netherlands: Superunie
Belgium: Colruyt Norway: Unil/NorgesGruppen
Czech Republic: MARKANT Portugal: EuromadiPort
Denmark: Dagrofa Slovakia: MARKANT
France: Francap South Korea: Lotte
Germany: RTG International Spain: Euromadi
Italy: ESD Italia Sweden: Dagab/Axfood
Luxemburg: Colruyt Switzerland: MARKANT
In addition to South Korea and Japan, associate member Lotte is also active in the Chinese, Vietnamese and Indonesian markets.
For further information:
Donati & Rosmanith
Uwe Rosmanith
Triq ir-Rumani, 3
Xlendi, XLN1431
Malta
Phone: +49 171 9706644
uwe@rosmanith.de
rosmanith@bettercommunications.mt
Images
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release
(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im
Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.
Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect24.2.2026 08:43:52 CET | Press release
Aachen, Germany & Victoria, Australia, 24 February 2026 – Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a topical, non-systemic, non-opioid patch indicated for the management of peripheral neuropathic pain. Under the agreement, Clinect will be responsible for obtaining marketing authorisation for Qutenza® in Australia and, upon approval, marketing and distributing the product in Australia.
Clean energy needs a clean planet: PLAN-B NET ZERO and everwave launch joint initiative20.2.2026 13:26:02 CET | Press release
(Berlin, Germany) A strong start to 2026. PLAN-B NET ZERO enters into a partnership with the Aachen-based environmental scale-up everwave. With the guiding principle ‘1 euro = 1 kilogram of waste’, the partners recovered 10,000 kilograms of waste from rivers in Cambodia at the start of the initiative Around 11 million tonnes of plastic waste enter the oceans every year. Without effective countermeasures, this volume could almost triple by 2040. Studies show that about 80 percent of marine plastic reaches the sea via roughly 1,656 rivers worldwide. To date, everwave has removed more than 2.4 million kilograms of plastic from rivers in Cambodia, Albania, and Thailand. The company uses waste collection boats, barriers, and manual cleanups to stop plastic before it reaches the oceans. At the same time, mobile sorting and recycling solutions return materials efficiently to the circular economy. AI support optimizes collection routes to clean as many waterways as possible in a sustainable wa
Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development18.2.2026 11:52:51 CET | Press release
Aachen, Germany, 18 February 2026 – Grünenthal announced today that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. The orally administered investigational medicine aims to provide a non-opioid therapy option across a range of acute and chronic pain conditions. Full results of the trial are expected in the second half of 2026.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

